The Fungal Meningitis Outbreak: Could It Have Been Prevented?

Panel I

Ms. Joyce Lovelace

• Witness Testimony (Truth in Testimony)

Panel II

Mr. Barry J. Cadden

• President, Co-Owner and Director of Pharmacy
• New England Compounding Center

Panel III

The Honorable Margaret A. Hamburg, M.D.

• Commissioner
• U.S. Food and Drug Administration (FDA)
• Witness Testimony (Truth in Testimony and CV)

Dr. Lauren Smith, MD, MPH

• Interim Commissioner
• Massachusetts Department of Public Health (MDPH)
• Witness Testimony (Truth in Testimony and CV)